CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- DEFA14A Proxy Proxy Materials
- SC 13D/A Stake Beneficial Ownership Report
- DFAN14A Other Proxy Soliciting Materials
- 4 Option exercise Director acquired 22,027 shares (option exercise)
- 4 Shares withheld for taxes EVP, President US gave up 41,869 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes President and CEO gave up 72,311 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 28,226 shares (to pay taxes)
- DEFA14A Proxy Proxy Materials
- DFAN14A Other Proxy Soliciting Materials
- DFAN14A Other Proxy Soliciting Materials
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Other events
- DEFA14A Proxy Proxy Materials
- DFAN14A Other Proxy Soliciting Materials
- DEFA14A Proxy Proxy Materials
- DFAN14A Other Proxy Soliciting Materials
- DEFA14A Proxy Proxy Materials
- DFAN14A Other Proxy Soliciting Materials
- SC 13D/A Stake Beneficial Ownership Report
Page 11 of 77 · 1,527 filings